J106-0236 Screening compound: 4-[1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carbonyl]-N,N-dimethylpiperazine-1-sulfonamide

J106-0236 Screening compound: 4-[1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carbonyl]-N,N-dimethylpiperazine-1-sulfonamide
J106-0236 Screening compound: 4-[1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carbonyl]-N,N-dimethylpiperazine-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J106-0236
4-[1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carbonyl]-N,N-dimethylpiperazine-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J106-0236

Molecular Formula

C18H24N6O4S (C18 H24 N6 O4 S)

Compound Name

4-[1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carbonyl]-N,N-dimethylpiperazine-1-sulfonamide

IUPAC name

4-[1-(1H-indazol-3-yl)-5-oxopyrrolidine-3-carbonyl]-NN-dimethylpiperazine-1-sulfonamide

SMILES

CN(C)S(N(CC1)CCN1C(C(CC1=O)CN1c1n[nH]c2c1cccc2)=O)(=O)=O

InChI

InChI=1S/C18H24N6O4S/c1-21(2)29(27,28)23-9-7-22(8-10-23)18(26)13-11-16(25)24(12-13)17-14-5-3-4-6-15(14)19-20-17/h3-6,13H,7-12H2,1-2H3,(H,19,20)/t13-/m0/s1

InChI Key

NWRABGKUWSJLJU-ZDUSSCGKSA-N

MDL Number (MFCD)

MFCD27963005

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.49

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.126

Distribution Coefficient, logD

0.126

Water Solubility, LogSw

-2.41

Polar Surface Area

91.923

Acid Dissociation Constant (pKa)

12.33

Base Dissociation Constant (pKb)

-2.85

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

J106-0236 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Mechanism of action:
  • PPI modulators
  • PPI modulators
Targets:
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with J106-0236 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J106-0236?
Check Price and Availability of J106-0236, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J106-0236 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J106-0236
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J106-0236
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J106-0236 available by request